App-Quantinova.ai

Fish Oil in Rheumatoid Arthritis: A Randomised, Double Blind Trial Comparing High Dose with Low Dose

Susanna Proudman - American College of Rheumatology (ACR) , 2012

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Rheumatoid arthritis

Hydroxychloroquine

Glucocorticoid use Is associated with increase in HDL in Rheumatoid Arthritis Patients

Lisa L. Schroeder - American College of Rheumatology (ACR) , 2012

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Rheumatoid arthritis

Hydroxychloroquine

Hydroxychloroquine Has Lipid-Lowering Effects in US Veterans with Rheumatoid Arthritis

Nicole A. Kieffer - American College of Rheumatology (ACR) , 2012

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Rheumatoid arthritis

Hydroxychloroquine

Hydroxychloroquine Reduces the Risk of Coronary Artery Disease in Patients with Rheumatoid Arthritis

Li Chun - American College of Rheumatology (ACR) , 2012

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Coronary Artery Disease

Hydroxychloroquine

Hydroxychloroquine Reduces Thrombosis in Systemic Lupus Erythematosus, Particularly in Antiphospholipid Positive Patients

Genevieve Law - American College of Rheumatology (ACR) , 2012

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Lupus

Hydroxychloroquine

Identifying a Link Between Uranium Exposure and Systemic Lupus Erythematosus in a Community Living near a Uranium Plant

Pai-Yue Lu - American College of Rheumatology (ACR) , 2012

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Lupus

Hydroxychloroquine

Increase in Vitamin D Improves Disease Activity and Systolic Blood Pressure in Systemic Lupus Erythematosus

Kayode J. Bello - American College of Rheumatology (ACR) , 2012

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Lupus

Hydroxychloroquine

Initiation of Tumor Necrosis Factor Alpha (TNF?) Antagonists and Risk of Fractures in Patients with Selected Rheumatic and Autoimmune Diseases

Vivian K. Kawai - American College of Rheumatology (ACR) , 2012

Therapeutic Area

Disease

Drug/Treatment

N/A

Hydroxychloroquine

Monitoring Patients with Systemic Lupus Erythematosus in Clinical Practice: Have You Already Checked the Vaccination Status in Your Patients?

Olga Malysheva - American College of Rheumatology (ACR) , 2012

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Lupus

Hydroxychloroquine

Patient Reported Outcomes in Early Arthritis Patients

L. Heimans - American College of Rheumatology (ACR) , 2012

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Inflammatory Arthritis

Hydroxychloroquine

Pro-Inflammatory and Pro-Thrombotic Markers in Persistently Antiphospholipid Antibody-Positive Patients with/without Systemic Lupus Erythematosus

Gurjot Basra - American College of Rheumatology (ACR) , 2012

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Lupus

Hydroxychloroquine

Remission After One Year in ACPA Positive and ACPA Negative Patients with Early Arthritis

K.V.C. Wevers-de Boer - American College of Rheumatology (ACR) , 2012

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Rheumatoid arthritis

Hydroxychloroquine

Rheumatoid Arthritis Comparison of Active Therapies in Methotrexate Suboptimal Responders: Validation of the Strategy of Conventional Disease Modifying Anti-Rheumatic Drugs Before Biologicals

James R. O Dell - American College of Rheumatology (ACR) , 2012

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Rheumatoid arthritis

Hydroxychloroquine

Secretagogue Use in Patients with Primary Sjogrens Syndrome

Ghaith Noaiseh - American College of Rheumatology (ACR) , 2012

Therapeutic Area

Disease

Drug/Treatment

Dental and Oral Health

Xerostomia

Hydroxychloroquine

Use of Anti-Tumor Necrosis Factor Monotherapy and Adherence with Non-Biologic Disease-Modifying Anti-Rheumatic Drugs in Combination with Anti-Tumor Necrosis Factor Therapy Among Rheumatoid Arthritis Patients in a Real-World Setting

Nicole M. Engel-Nitz - American College of Rheumatology (ACR) , 2012

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Rheumatoid arthritis

Hydroxychloroquine

A Randomized, Dose-Ranging, Placebo-Controlled, 84-Day Study Of INCB039110, a Selective Janus Kinase-1 Inhibitor, In Patients With Active Rheumatoid Arthritis

Monica Luchi - American College of Rheumatology (ACR) , 2013

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Rheumatoid arthritis

Hydroxychloroquine

Abatacept Reduces Disease Activity In Early Primary Sjogrens Syndrome:One Year Results From a Phase II Open-Label Study

PM Meiners - American College of Rheumatology (ACR) , 2013

Therapeutic Area

Disease

Drug/Treatment

N/A

Hydroxychloroquine

Anti-Malarial Drugs (hydroxychloroquine and quinacrine) Decrease The Production Of Interferon-Alfa Initiated By TLR-9 Agonist

Ou Jin - American College of Rheumatology (ACR) , 2013

Therapeutic Area

Disease

Drug/Treatment

N/A

Hydroxychloroquine

Association Between Hydroxychloroquine Exposure and Incidence Of Diabetes Mellitus In Systemic Lupus Erythematosus

Michelle Petri - American College of Rheumatology (ACR) , 2013

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Lupus

Hydroxychloroquine

Better Cost-Effectiveness and Worker Productivity In Triple DMARD Therapy Versus Methotrexate Monotherapy In Early Rheumatoid Arthritis; Cost-Utility Analysis Of The Treach Trial

P.H.P. de Jong - American College of Rheumatology (ACR) , 2013

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Rheumatoid arthritis

Hydroxychloroquine

Filters

1151 Abstracts